Pipeline · Bill → Law
Step 1
Introduced
Jun 22, 2023
Step 2
Referred
Jun 22, 2023
Finance
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Timeline · 2 actions
Jun 22, 2023
Introduced in Senate
Jun 22, 2023
Read twice and referred to the Committee on Finance.